Gene · 100126325
Papers1,500
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,500
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| M6A-dependent regulation of microRNAs from CKD stage 5 patients: insights from epigenetic modification analysis. | Epigenetics | 2026 | 41945665 | PubTator, text mining | PubMed |
| Histochemical characterization of muscularis macrophage loss and disruption of a miR-93-5p-AHNAK neuro-immune axis in Hirschsprung's disease. | Histochem Cell Biol | 2026 | 41933096 | PubTator, text mining | PubMed |
| Differential MicroRNA Expression in Chronic Spontaneous Urticaria in Relation to Treatment Response. | Allergy Asthma Immunol Res | 2026 | 41914533 | PubTator, text mining | PubMed |
| SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC. | Cells | 2026 | 41892339 | PubTator, text mining | PubMed |
| Extracellular vesicle miR-93-5p cargo regulates glomerular endothelial cell damage in Alport syndrome. | JCI Insight | 2026 | 41869725 | PubTator, text mining | PubMed |
| Development of microRNA-Based Glioblastoma Biomarkers Using Blood Plasma Specimens. | Diagnostics (Basel) | 2026 | 41828067 | PubTator, text mining | PubMed |
| MicroRNAs miR-29a-3p and miR-192-5p: promising urinary biomarkers for kidney function loss. | Arch Endocrinol Metab | 2026 | 41805287 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Potential Molecular Targets in Juvenile Dermatomyositis. | Biochem Res Int | 2026 | 41797822 | PubTator, text mining | PubMed |
| Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA. | Invest Ophthalmol Vis Sci | 2026 | 41773772 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
| An Exploratory Biomarker Study of First-Trimester Circulating miRNAs Associated with Later Gestational Diabetes Mellitus. | Int J Mol Sci | 2026 | 41752058 | PubTator, text mining | PubMed |
| MicroRNA as Potential Biomarkers and Their Pathogenesis in Multiple System Atrophy. | Int J Mol Sci | 2026 | 41752011 | PubTator, text mining | PubMed |
| Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression. | Biomolecules | 2026 | 41750312 | PubTator, text mining | PubMed |
| miRNA-Based Breast Cancer Subtyping Using AHALA Multi-Stage Classification Approach. | Cancers (Basel) | 2026 | 41749839 | PubTator, text mining | PubMed |
| Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma. | PeerJ | 2026 | 41727220 | PubTator, text mining | PubMed |
| Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications. | Research (Wash D C) | 2026 | 41716844 | PubTator, text mining | PubMed |
| Multi-Omics Evidence Based on Spatial Transcriptomics Data Reveals the Therapeutic Value of Copper Death Genes in Glioblastoma. | Int J Genomics | 2026 | 41626626 | PubTator, text mining | PubMed |
| Significance of MALAT1 long non-coding RNA and miR-20a-5p in regulating epithelial mesenchymal transition in luminal breast cancer patients. | J Egypt Natl Canc Inst | 2026 | 41622408 | PubTator, text mining | PubMed |
| Exosomal miR-93-5p modulates macrophage polarization to enhance prostate cancer progression. | Arch Biochem Biophys | 2026 | 41617125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100126325/papers?page=2